MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
CLDX Celldex Therapeutics
- 25.140
- -0.240-0.95%
Close Dec 20 16:00 ET
- 25.140
- 0.0000.00%
Post 20:01 ET
1.67BMarket Cap-9.74P/E (TTM)
25.950High24.830Low2.17MVolume25.180Open25.380Pre Close54.73MTurnover3.46%Turnover RatioLossP/E (Static)66.34MShares53.18052wk High2.12P/B1.58BFloat Cap22.92952wk Low--Dividend TTM62.70MShs Float3374.997Historical High--Div YieldTTM4.41%Amplitude1.500Historical Low25.261Avg Price1Lot Size
Celldex Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | 221.23%756M | 217.50%802.32M | 195.94%823.85M | 38.91%423.6M | 38.91%423.6M | -27.24%235.35M | -29.18%252.7M | -26.83%278.39M | -25.30%304.95M | -25.30%304.95M |
| -Cash and cash equivalents | 72.23%36.4M | 51.43%42.74M | 112.62%115.08M | 18.30%34.81M | 18.30%34.81M | 13.73%21.13M | -0.62%28.22M | 113.98%54.12M | -24.82%29.43M | -24.82%29.43M |
| -Short-term investments | 235.93%719.6M | 238.38%759.58M | 216.04%708.77M | 41.11%388.78M | 41.11%388.78M | -29.74%214.21M | -31.65%224.47M | -36.86%224.26M | -25.35%275.52M | -25.35%275.52M |
| Receivables | 238.10%852K | 1,200.00%1.53M | 103.27%2.67M | 657.35%2.63M | 657.35%2.63M | 33.33%252K | 21.65%118K | 440.74%1.31M | 101.74%347K | 101.74%347K |
| -Accounts receivable | 238.10%852K | 1,200.00%1.53M | 103.27%2.67M | 657.35%2.63M | 657.35%2.63M | 33.33%252K | 21.65%118K | 440.74%1.31M | 101.74%347K | 101.74%347K |
| Other current assets | 112.82%21.99M | -32.33%8.12M | -11.00%8.81M | -55.89%5.47M | -55.89%5.47M | -5.54%10.33M | 8.50%12.01M | -0.92%9.9M | 412.78%12.39M | 412.78%12.39M |
| Total current assets | 216.69%778.84M | 206.61%811.98M | 188.44%835.32M | 35.88%431.69M | 35.88%431.69M | -26.50%245.93M | -28.03%264.82M | -25.88%289.6M | -22.67%317.69M | -22.67%317.69M |
| Non current assets | ||||||||||
| Net PPE | 5.32%7.4M | -12.23%6.31M | -18.38%6.23M | -14.34%6.64M | -14.34%6.64M | -4.19%7.03M | -6.43%7.19M | 26.12%7.63M | 18.82%7.75M | 18.82%7.75M |
| -Gross PPE | 5.32%7.4M | -12.23%6.31M | -18.38%6.23M | -1.20%29.02M | -1.20%29.02M | -4.19%7.03M | -6.43%7.19M | 26.12%7.63M | 6.25%29.37M | 6.25%29.37M |
| -Accumulated depreciation | ---- | ---- | ---- | -3.51%-22.39M | -3.51%-22.39M | ---- | ---- | ---- | -2.37%-21.63M | -2.37%-21.63M |
| Goodwill and other intangible assets | 0.00%27.19M | 0.00%27.19M | 0.00%27.19M | 0.00%27.19M | 0.00%27.19M | 0.00%27.19M | 0.00%27.19M | 0.00%27.19M | 0.00%27.19M | 0.00%27.19M |
| -Other intangible assets | ---- | ---- | ---- | 0.00%27.19M | 0.00%27.19M | ---- | ---- | 0.00%27.19M | 0.00%27.19M | 0.00%27.19M |
| Other non current assets | 9,009.35%9.75M | 0.00%107K | 2.88%107K | 2.88%107K | 2.88%107K | 2.88%107K | 2.88%107K | 0.00%104K | 0.00%104K | 0.00%104K |
| Total non current assets | 29.18%44.34M | -2.55%33.61M | -4.01%33.52M | -3.16%33.93M | -3.16%33.93M | -0.88%34.32M | -1.40%34.49M | 4.74%34.92M | 3.63%35.04M | 3.63%35.04M |
| Total assets | 193.72%823.18M | 182.51%845.59M | 167.73%868.85M | 32.00%465.63M | 32.00%465.63M | -24.10%280.26M | -25.72%299.31M | -23.47%324.52M | -20.67%352.74M | -20.67%352.74M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -68.93%1.11M | 331.56%3.8M | -4.15%3.23M | 4.61%3.49M | 4.61%3.49M | 57.83%3.59M | -94.46%881K | 231.11%3.37M | 171.99%3.34M | 171.99%3.34M |
| -accounts payable | -68.93%1.11M | 331.56%3.8M | -4.15%3.23M | 4.61%3.49M | 4.61%3.49M | 57.83%3.59M | -2.33%881K | 231.11%3.37M | 171.99%3.34M | 171.99%3.34M |
| Current accrued expenses | 52.69%28.2M | 51.70%18.59M | 87.07%17.54M | 71.63%22.03M | 71.63%22.03M | 61.67%18.47M | 9.15%12.26M | 1.52%9.37M | 6.96%12.84M | 6.96%12.84M |
| Current debt and capital lease obligation | -10.86%1.38M | 3.86%1.59M | 10.11%1.64M | 11.70%1.61M | 11.70%1.61M | 7.58%1.55M | 7.37%1.53M | -17.15%1.49M | -17.24%1.45M | -17.24%1.45M |
| -Current capital lease obligation | -10.86%1.38M | 3.86%1.59M | 10.11%1.64M | 11.70%1.61M | 11.70%1.61M | 7.58%1.55M | 7.37%1.53M | -17.15%1.49M | -17.24%1.45M | -17.24%1.45M |
| Other current liabilities | -67.01%1.4M | 275.56%3.67M | 296.42%3.88M | 302.83%3.99M | 302.83%3.99M | 267.36%4.23M | -29.79%978K | -60.96%978K | -36.29%990K | -36.29%990K |
| Current liabilities | 15.29%32.09M | 76.77%27.66M | 72.75%26.29M | 67.25%31.13M | 67.25%31.13M | 70.91%27.84M | -47.76%15.65M | 4.53%15.22M | 12.60%18.61M | 12.60%18.61M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | 31.49%1.71M | -53.86%796K | -78.21%470K | -64.14%928K | -64.14%928K | -40.68%1.3M | -33.29%1.73M | 156.48%2.16M | 99.69%2.59M | 99.69%2.59M |
| -Long term capital lease obligation | 31.49%1.71M | -53.86%796K | -78.21%470K | -64.14%928K | -64.14%928K | -40.68%1.3M | -33.29%1.73M | 156.48%2.16M | 99.69%2.59M | 99.69%2.59M |
| Other non current liabilities | -21.12%3.47M | -21.12%3.47M | -21.12%3.47M | -17.44%4.4M | -17.44%4.4M | -17.44%4.4M | -17.44%4.4M | -58.22%4.4M | -27.48%5.33M | -27.48%5.33M |
| Total non current liabilities | -9.14%5.18M | -30.34%4.27M | -39.89%3.94M | -32.70%5.33M | -32.70%5.33M | -24.21%5.7M | -22.62%6.13M | -42.36%6.56M | -8.43%7.92M | -8.43%7.92M |
| Total liabilities | 11.14%37.27M | 46.63%31.93M | 38.82%30.23M | 37.41%36.46M | 37.41%36.46M | 40.86%33.54M | -42.50%21.77M | -16.04%21.78M | 5.37%26.53M | 5.37%26.53M |
| Shareholders'equity | ||||||||||
| Share capital | 40.43%66K | 40.43%66K | 40.43%66K | 19.15%56K | 19.15%56K | 0.00%47K | 0.00%47K | 0.00%47K | 0.00%47K | 0.00%47K |
| -common stock | 40.43%66K | 40.43%66K | 40.43%66K | 19.15%56K | 19.15%56K | 0.00%47K | 0.00%47K | 0.00%47K | 0.00%47K | 0.00%47K |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | -11.38%-1.51B | -11.42%-1.47B | -11.27%-1.43B | -11.26%-1.4B | -11.26%-1.4B | -10.14%-1.35B | -9.41%-1.32B | -10.17%-1.29B | -9.82%-1.26B | -9.82%-1.26B |
| Paid-in capital | 43.17%2.29B | 43.15%2.28B | 42.92%2.27B | 15.33%1.82B | 15.33%1.82B | 1.50%1.6B | 1.47%1.59B | 1.36%1.59B | 1.26%1.58B | 1.26%1.58B |
| Gains losses not affecting retained earnings | 147.68%5.29M | -14.09%1.78M | 5.70%2.24M | 162.54%3.31M | 162.54%3.31M | 2,006.25%2.14M | 596.88%2.07M | 1,795.54%2.12M | -33.47%1.26M | -33.47%1.26M |
| Total stockholders'equity | 218.54%785.91M | 193.17%813.66M | 177.01%838.61M | 31.57%429.17M | 31.57%429.17M | -28.57%246.72M | -23.98%277.54M | -23.95%302.74M | -22.24%326.2M | -22.24%326.2M |
| Total equity | 218.54%785.91M | 193.17%813.66M | 177.01%838.61M | 31.57%429.17M | 31.57%429.17M | -28.57%246.72M | -23.98%277.54M | -23.95%302.74M | -22.24%326.2M | -22.24%326.2M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.